LON:AOR AorTech International (AOR) Share Price, News & Analysis → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Free AOR Stock Alerts GBX 123.50 -3.00 (-2.37%) (As of 06/18/2020) Add Compare Share Share Today's Range 122▼ 12650-Day Range 123.50▼ 123.5052-Week Range 40.50▼ 134.70Volume7,419 shsAverage Volume40,686 shsMarket Capitalization£19.99 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get AorTech International alerts: Email Address Ad Stansberry ResearchMove Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. About AorTech InternationalAorTech International plc, together with its subsidiaries, focuses on the commercialization of its biomedical polymer technology, components, and medical devices in the United Kingdom. The company offers Elast-Eon, a bio stable polyurethane material used in long term implantation; and Elast-Eon Carbonate Silicone, a family of biomedical polymers for applications in cardiac pacing leads, orthopedics, and spinal discs, as well as in other applications where the device requires a high level of mechanical performance. It also provides Elast-Eon Reaction Injection Molding products for use in high-precision medical device components. In addition, the company licenses its technology; and offers support services to other medical device companies. AorTech International plc was incorporated in 1996 and is headquartered in Weybridge, the United Kingdom.Read More AOR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AOR Stock News HeadlinesApril 24, 2023 | marketwatch.com2023-2030 Bioprosthetics Market Size with [95 Pages] includes Industry Chain Analysis | New Report by Absolute ReportsMarch 30, 2023 | marketwatch.comElectrophysiology (EP) Ablation Catheters Market by 2031April 26, 2024 | Weiss Ratings (Ad)The Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.March 20, 2023 | marketwatch.comBioprosthetics Market Major Players, Anlysis and Forecast till 2028March 4, 2023 | marketwatch.comGlobal Bioprosthetics Market 2023 Growth Opportunities, Top Players, Regions, Application, and Forecast to 2030 By VMReportsFebruary 16, 2023 | marketwatch.comMechanical Heart Valve Market Outlook 2023 and Forecast to 2028 with Top Countries DataJanuary 18, 2023 | marketwatch.comMechanical Heart Valve Market 2023 : Manufacturers Strategies, Share Estimation, Future Demand and Regional Growth Dynamics 2029September 21, 2022 | marketwatch.comPercutaneous Mitral Valve Repair Device Market 2022-2028 Leading Growth Drivers, Emerging Audience, Segments, Industry Sales, Profits & AnalysisApril 26, 2024 | Weiss Ratings (Ad)The Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.June 10, 2022 | marketwatch.comCardiac Valve Market-Industry Analysis, Share, Size Trends, Demand, Growth, Revenue, Top Companies and Forecasts 2022 to 2028December 16, 2021 | lse.co.ukTRADING UPDATES: Listing costs hobble Orcadian and ProCook earningsOctober 20, 2021 | ca.finance.yahoo.comGlobal Bioprosthetics Market Research Report (2021 to 2026) - by Type, Application and Region - ResearchAndMarkets.comSeptember 2, 2021 | proactiveinvestors.comRUA Life Sciences - Result of AGMAugust 31, 2021 | proactiveinvestors.comRUA Life Sciences - AGM Statement and Trading UpdateAugust 10, 2021 | proactiveinvestors.comRUA Life Sciences - Directorate ChangeSee More Headlines Receive AOR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AorTech International and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:AOR CUSIPN/A CIKN/A Webwww.aortech.net Phone+44-1932-252123FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio32.06 Quick Ratio32.06 Sales & Book Value Annual Sales£539,000.00 Price / Sales37.09 Cash FlowGBX 14.82 per share Price / Cash Flow8.33 Book ValueGBX 19.40 per share Price / Book6.37Miscellaneous Outstanding Shares16,186,600Free FloatN/AMarket Cap£19.99 million OptionableNot Optionable BetaN/A 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. William Donald Brown (Age 55)CEO, Exec. Chairman & Fin. Director Mr. John McKenna (Age 66)Director of Clinical Marketing & Exec. Director Mr. Ajay Padsalgikar Ph.D.Chief Scientific OfficerMr. David J. C. ParsonsCompany Sec.Key CompetitorsDestiny PharmaLON:DESTOxford BioDynamicsLON:OBDOncimmuneLON:ONCHemogenyx PharmaceuticalsLON:HEMOSkinBioTherapeuticsLON:SBTXView All Competitors AOR Stock Analysis - Frequently Asked Questions How have AOR shares performed in 2024? AorTech International's stock was trading at GBX 123.50 at the beginning of the year. Since then, AOR stock has increased by 0.0% and is now trading at GBX 123.50. View the best growth stocks for 2024 here. What other stocks do shareholders of AorTech International own? Based on aggregate information from My MarketBeat watchlists, some companies that other AorTech International investors own include KAZ Minerals (KAZ), Standard Chartered (STAN), Ascential (ASCL), Empyrean Energy (EME), Lloyds Banking Group (LYG), Starbucks (SBUX), Activision Blizzard (ATVI), Alphabet (GOOG), Petropavlovsk (POG) and Scancell (SCLP). How do I buy shares of AorTech International? Shares of AOR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:AOR) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithMan Who Predicted 2008: “This Will be Worse.”AltimetryFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AorTech International plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
